Key Dates

Related Announcements

• July 12, 2023 - Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required). See NOFO RFA-MH-24-150.

Issued by

National Institute of Mental Health (NIMH)

Purpose

The National Institute of Mental Health (NIMH) will host a pre-application and technical assistance webinar on August 9, 2023, 12:00 - 1:00 pm Eastern Time (ET) to provide information and respond to questions from prospective applicants who plan to submit applications in response to RFA-MH-24-150, Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required).

NIMH staff members involved in managing RFA-MH-24-150 will provide an overview of the RFA, including objectives, application instructions, and review criteria, and will be available to answer questions.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-MH-24-150.

Webinar Information

The webinar will be hosted through ZoomGov Meeting: https://nih.zoomgov.com/j/1619898117?pwd=cXRQNTFjZGg2T2V0RG9IYUV5U2ZUZz09

Date: August 9, 2023

Time: 12:00 to 1:00 p.m. Eastern Time (ET)

Participants requiring sign language interpretation and/or other reasonable accommodations should contact jonathan.sabbagh@nih.gov at least 5 days prior to the event.

Participants can submit questions in advance to jonathan.sabbagh@nih.gov.

Inquiries

Please direct all inquiries to:

Jonathan Sabbagh, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-594-2557
Email: jonathan.sabbagh@nih.gov